Table 1. Patient characteristics at... | American Society of Hematology

Table 1.

Patient characteristics at transplantation for 33 patients younger than 17 years

UPN	Sex	Country	Age, y	No. of Tx	CI	Ferritin, ng/mL	GOT, U/L	GPT, U/L	LIC, mg/g dry weight	FS	CAH
1211	F	Albania	16	230	100	2591	49	60	30.9	Mo	No
1230	F	Italy	16	290	100	3221	42	60	13.6	Se	Yes
1231	F	Kuwait	11	75	100	1900	16	32	8.2	Mi	No
1236	M	Saudi Arabia	16	200	100	2557	31	29	28.3	Ci	Yes
1262	F	Albania	12	200	100	4533	77	55	30.1	Se	No
1288	M	Saudi Arabia	12	150	37	968	41	43	15.8	Mi	No
1292	M	Kuwait	9	80	100	1624	34	31	24.5	Mo	Yes
1319	M	Syria	16	200	100	1087	27	20	7.8	Ci	No
1324	F	Pakistan	10	125	13	1391	35	24	20.5	Mo	Yes
1331	F	Kuwait	12	118	100	3558	47	72	38.1	Ci	Yes
1339	F	Lebanon	12	100	100	3158	34	45	26.4	Mo	Yes
1342	F	Palestine	6	90	54	1967	37	57	28.7	Mo	No
1347	F	Kuwait	4	18	100	4016	220	260	15.5	Se	No
1357	F	Saudi Arabia	9	80	10	1140	31	28	7.5	Mi	No
1362	M	Libya	9	18	100	1226	30	51	0.9	Mo	No
1363	M	Nepal	4	6	100	1925	67	65	15.7	Mi	No
1371	F	Albania	14	130	100	2067	48	69	30.5	Se	No
1372	F	Kuwait	15	200	100	6300	13	13	30.2	Mo	No
1374	M	Jordan	7	30	100	4463	66	88	40.1	Se	No
1375	M	Italy	10	130	5	2721	27	52	14.4	Se	No
1389	F	Iran	14	150	49	2835	29	16	19	Mi	No
1409	M	Iraq	5	70	100	2338	55	93	20.3	Se	No
1413	F	Kuwait	9	106	100	2449	32	27	9.3	Mo	Yes
1414	F	Saudi Arabia	15	120	100	5306	12	18	14.4	Mo	Yes
1427	F	Italy	14	280	100	3386	32	30	17.4	Mo	No
1429	M	Romania	11	10	100	1000	39	37	4.9	Mo	Yes
1435	M	Pakistan	10	60	100	3492	16	23	15.8	Mo	Yes
1444	M	Palestine	8	90	100	3231	51	48	20.1	Se	Yes
1445	F	Palestine	11	120	100	953	38	26	2.7	Mo	Yes
1448	M	Palestine	16	130	100	4578	47	38	38.1	Ci	Yes
1449	M	Palestine	15	80	100	2120	31	43	4.2	Mi	No
1454	M	Palestine	5	60	100	1619	31	42	18.8	Mo	Yes
1457	M	Albania	12	140	100	1257	79	45	14.1	Mo	Yes

UPN	Sex	Country	Age, y	No. of Tx	CI	Ferritin, ng/mL	GOT, U/L	GPT, U/L	LIC, mg/g dry weight	FS	CAH
1211	F	Albania	16	230	100	2591	49	60	30.9	Mo	No
1230	F	Italy	16	290	100	3221	42	60	13.6	Se	Yes
1231	F	Kuwait	11	75	100	1900	16	32	8.2	Mi	No
1236	M	Saudi Arabia	16	200	100	2557	31	29	28.3	Ci	Yes
1262	F	Albania	12	200	100	4533	77	55	30.1	Se	No
1288	M	Saudi Arabia	12	150	37	968	41	43	15.8	Mi	No
1292	M	Kuwait	9	80	100	1624	34	31	24.5	Mo	Yes
1319	M	Syria	16	200	100	1087	27	20	7.8	Ci	No
1324	F	Pakistan	10	125	13	1391	35	24	20.5	Mo	Yes
1331	F	Kuwait	12	118	100	3558	47	72	38.1	Ci	Yes
1339	F	Lebanon	12	100	100	3158	34	45	26.4	Mo	Yes
1342	F	Palestine	6	90	54	1967	37	57	28.7	Mo	No
1347	F	Kuwait	4	18	100	4016	220	260	15.5	Se	No
1357	F	Saudi Arabia	9	80	10	1140	31	28	7.5	Mi	No
1362	M	Libya	9	18	100	1226	30	51	0.9	Mo	No
1363	M	Nepal	4	6	100	1925	67	65	15.7	Mi	No
1371	F	Albania	14	130	100	2067	48	69	30.5	Se	No
1372	F	Kuwait	15	200	100	6300	13	13	30.2	Mo	No
1374	M	Jordan	7	30	100	4463	66	88	40.1	Se	No
1375	M	Italy	10	130	5	2721	27	52	14.4	Se	No
1389	F	Iran	14	150	49	2835	29	16	19	Mi	No
1409	M	Iraq	5	70	100	2338	55	93	20.3	Se	No
1413	F	Kuwait	9	106	100	2449	32	27	9.3	Mo	Yes
1414	F	Saudi Arabia	15	120	100	5306	12	18	14.4	Mo	Yes
1427	F	Italy	14	280	100	3386	32	30	17.4	Mo	No
1429	M	Romania	11	10	100	1000	39	37	4.9	Mo	Yes
1435	M	Pakistan	10	60	100	3492	16	23	15.8	Mo	Yes
1444	M	Palestine	8	90	100	3231	51	48	20.1	Se	Yes
1445	F	Palestine	11	120	100	953	38	26	2.7	Mo	Yes
1448	M	Palestine	16	130	100	4578	47	38	38.1	Ci	Yes
1449	M	Palestine	15	80	100	2120	31	43	4.2	Mi	No
1454	M	Palestine	5	60	100	1619	31	42	18.8	Mo	Yes
1457	M	Albania	12	140	100	1257	79	45	14.1	Mo	Yes

UPN indicates unique patient number; No. of Tx, number of red cell transfusions before transplantation; CI, chelation index; GOT, glutamic-oxaloacetic transaminase; GPT, glutamic-pyruvic transaminase; LIC, liver iron concentration; FS, portal fibrosis (Mi, mild; Mo, moderate; Se, severe; Ci, cirrhotic); CAH, chronic active hepatitis (yes, present; no, absent)

View Large

This Feature Is Available To Subscribers Only